Celleron Therapeutics enrols patients for clinical trial
Celleron Therapeutics, spun out of the University in 2005, has commenced a Phase Ib/II clinical trial investigating drug combination therapy for colorectal cancer.
We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
Celleron Therapeutics, spun out of the University in 2005, has commenced a Phase Ib/II clinical trial investigating drug combination therapy for colorectal cancer.
Support-HF, developed by The George Institute for Global Health at the University of Oxford and Oxford University Hospitals NHS Foundation Trust, will support patients and clinicians in managing heart failure and curate data for medical research using Clinical AI.
Oxford University spinout external investment nears £1.9bn since 2011 - £506m of which was in the past twelve months.
Oxford University Innovation licenses sensors for garlic, ginger and turmeric to Zimmer and Peacock.
Opsydia, an Oxford University spinout founded last year to create a new level of diamond and gemstone security, officially launches with De Beers deal.
Oxford Sciences Innovation leads round into Orbit Discovery, an Oxford University spinout developing a peptide platform.
Oxford University spinout Cytox has announced an extension of its test for assessing the genetic risk of developing Alzheimer's disease.
Preserving livers at body temperature has been shown to improve transplant success and to increase the number of viable donor livers available for transplant. The study, which used a normothermic perfusion device from spinout OrganOx, presages shorter waiting lists for patients and lower mortality rates.
Momentum behind the Oxford innovation ecosystem keeps building, with a third of spinouts formed over OUI's 30 year history created in the past three years.
Brainomix builds on partnership with Boehringer Ingelheim for AI-assisted fast treatment of stroke victims in latest venture round.